Number (%) of participants in proficiency tests for antibody screening
Trial | Specimen | No. or participants (%) | Negative (%) | Positive (%) | Intended response |
---|---|---|---|---|---|
1st | BBG-19-01 | 316 (100) | 1 (0.3) |
315 (99.7) | Positive |
BBG-19-02 | 316 (100) | 1 (0.3) |
315 (99.7) | Positive | |
BBG-19-03 | 316 (100) | 316 (100) | 0 | Negative | |
2nd | BBG-19-07 | 317 (100) | 316 (99.7) | 1 (0.3) | Negative |
BBG-19-08 | 317 (100) | 0 | 317 (100) | Positive | |
BBG-19-09 | 317 (100) | 1 (0.3) |
316 (99.7) | Positive |
*Unacceptable responses for antibody screening,